Abstract
Chronic wounds display aberrant wound healing or wound healing that deviates from normal. The term ‘chronic wounds’, implies that these wounds do not heal in a timely fashion. They are often predisposed to infection, and not uncommonly result in amputation. Growth factors and cytokines play a pivotal role in cutaneous wound healing. It has been noted that some growth factors are deficient in chronic wounds, therefore it has been suggested that local or topical application of these factors may compensate for any deficiency and allow normal wound healing to progress. This paper reviews current work on the application of topical growth factors to wounds. Some potential problems are identified and suggestions are made for future areas where research may improve the effectiveness of this form of therapy.
Keywords: Wound healing, growth factors, topical administration
Current Drug Delivery
Title: The Role of Topical Growth Factors in Chronic Wounds
Volume: 4 Issue: 3
Author(s): Rhiannon Braund, Sarah Hook and Natalie J. Medlicott
Affiliation:
Keywords: Wound healing, growth factors, topical administration
Abstract: Chronic wounds display aberrant wound healing or wound healing that deviates from normal. The term ‘chronic wounds’, implies that these wounds do not heal in a timely fashion. They are often predisposed to infection, and not uncommonly result in amputation. Growth factors and cytokines play a pivotal role in cutaneous wound healing. It has been noted that some growth factors are deficient in chronic wounds, therefore it has been suggested that local or topical application of these factors may compensate for any deficiency and allow normal wound healing to progress. This paper reviews current work on the application of topical growth factors to wounds. Some potential problems are identified and suggestions are made for future areas where research may improve the effectiveness of this form of therapy.
Export Options
About this article
Cite this article as:
Rhiannon Braund , Sarah Hook and Natalie J. Medlicott , The Role of Topical Growth Factors in Chronic Wounds, Current Drug Delivery 2007; 4 (3) . https://dx.doi.org/10.2174/156720107781023857
DOI https://dx.doi.org/10.2174/156720107781023857 |
Print ISSN 1567-2018 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5704 |
Call for Papers in Thematic Issues
Electrospun Fibers as Drug Delivery Systems
In recent years, electrospun fibers have attracted considerable attention as potential platforms for drug delivery due to their distinctive properties and adaptability. These fibers feature a notable surface area-to-volume ratio and can be intentionally designed with high porosity, facilitating an increased capacity for drug loading and rendering them suitable for ...read more
Emerging Nanotherapeutics for Mitigation of Neurodegenerative Disorders
Conditions affecting the central nervous system (CNS) present a significant hurdle due to limited access to both treatments and diagnostic tools for the brain. The blood-brain barrier (BBB) acts as a barrier, restricting the passage of molecules from the bloodstream into the brain. The most formidable challenge facing scientists is ...read more
Exosome-Based Drug Delivery for Regenerative Medicine
Exosome-based drug delivery is emerging as a transformative technology in regenerative medicine due to exosomes' natural ability to mediate intercellular communication and carry bioactive molecules like proteins, lipids, and nucleic acids. This thematic issue focuses on exosomes as nanocarriers for therapeutic delivery, harnessing their potential to enhance tissue repair, immune ...read more
Extracellular Vesicles as Drug Delivery Systems.
Extracellular vesicles (EVs) are membranous vesicles released from almost all types of cells into extracellular space. EVs are categorized into different types including exosome (~30-150 nm), microvesicle or microparticle (~100-1,000 nm), apoptotic body (~1,000-5,000 nm), and others produced by different mechanisms. Since EVs bear the molecules (e.g., specific lipids, carbohydrates, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Myocardial Infarction after Rituximab Treatment for Rheumatoid Arthritis: Is there a Link?
Current Pharmaceutical Design Protective Effects of Diuretics Against the Development of Cardiovascular Disease in Patients with Chronic Kidney Disease: A Systematic Review
Cardiovascular & Hematological Agents in Medicinal Chemistry Characterization of a New Impurity in Metaraminol Bitartrate for Injection by 2D HPLC-Q/TOF-MS, Chemical Synthesis and NMR
Current Pharmaceutical Analysis Combinations of Renin-Angiotensin-Aldosterone System Antagonists:True Advantages?
Current Pharmaceutical Design Clinical Uses of Melatonin: Evaluation of Human Trials
Current Medicinal Chemistry Elucidation of Abnormal Extracellular Regulated Kinase (ERK) Signaling and Associations with Syndromic and Non-syndromic Autism
Current Drug Targets Editorial from Editor-in-Chief (Thrombolytic and Catheter-Directed Therapy for Pulmonary Embolism: The Paradox of Clinical Outcomes and Theory)
Current Respiratory Medicine Reviews Purinergic Signalling and Endothelium
Current Vascular Pharmacology Update on Anti-TNF-Alpha Treatment in Rheumatic Diseases
Current Drug Therapy De novo Designed Lipopolysaccharide Binding Peptides: Structure Based Development of Antiendotoxic and Antimicrobial Drugs
Current Medicinal Chemistry Platelet Aggregation and Exogenous Factors From Animal Sources
Current Drug Targets - Cardiovascular & Hematological Disorders Mechanisms of Esophageal Protection, Gastroprotection and Ulcer Healing by Melatonin. Implications for the Therapeutic use of Melatonin in Gastroesophageal Reflux Disease (GERD) and Peptic Ulcer Disease
Current Pharmaceutical Design Role of the Sympathetic Nervous Activity in Hypertension-Update in 2013
Current Hypertension Reviews NO-NSAIDs: From Inflammatory Mediators to Clinical Readouts
Inflammation & Allergy - Drug Targets (Discontinued) Stress Echocardiography
Current Pharmaceutical Design Antibacterial Effects of Carbon Monoxide
Current Pharmaceutical Biotechnology Invasive Aspergillosis: New Insights into Disease, Diagnostic and Treatment
Current Pharmaceutical Design Fourth Generation of Synthetic Cannabinoid Receptor Agonists: A Review on the Latest Insights
Current Pharmaceutical Design Endogenous Cardioprotective Agents: Role in Pre and Postconditioning
Current Drug Targets Gene Polymorphism of Angiotensin II Type 1 and Type 2 Receptors
Current Pharmaceutical Design